About the Company
We do not have any company description for COGNITION THERAPEUTICS INC at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on COGNITION THERAPEUTICS INC
Cognition Therapeutics Shares Surge After FDA Confirms Phase 3 Trial Design
Cognition Therapeutics Inc (NASDAQ:CGTX) saw its stock jump 27% following FDA confirmation that the company’s proposed Phase ...
Cognition Therapeutics, Inc. Transitions to Nasdaq Capital Market ...
Cognition Therapeutics, Inc. announced on March 12, 2025, that it has been notified by Nasdaq of its transfer from The Nasdaq Global Market to The Nasdaq Capital Market due to the company’s ...
Cognition Therapeutics Reports Q2 2025 Financial Results
Cognition Therapeutics, Inc. ( ($CGTX) ) has released its Q2 earnings. Here is a breakdown of the information Cognition Therapeutics, Inc.
VIDEO: Zervimesine slows dementia with lewy bodies progression
In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association International ...
Cognition Therapeutics Inc (CGTX) Q4 2024 Earnings Call Highlights ...
Cognition Therapeutics Inc (NASDAQ:CGTX) has sufficient cash to fund operations into the fourth quarter of 2025, supported by a $50 million balance in obligated grant funds from the NIA.
Cognition Therapeutics, Inc. CEO Lisa Ricciardi to Present at Life ...
Cognition Therapeutics, Inc. announced that its President and CEO, Lisa Ricciardi, will present at the Life Sciences Virtual Investor Conference on March 13, 2025, at 9:30 a.m. ET.
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Consensus ...
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has received an average rating of “Buy” from the six brokerages that are presently covering the firm, Marketbeat reports.
Cognition Therapeutics, Inc. (CGTX) Q2 2023 Earnings Call Transcript
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q2 2023 Earnings Conference Call August 8, 2023 8:00 AM ETCompany ParticipantsDaniel Kontoh-Boateng - Investor ...
Cognition Therapeutics, Inc.: Cognition Therapeutics Publishes Research ...
About Cognition Therapeutics, Inc. Cognition Therapeutics, Inc., is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age ...
Cognition Therapeutics Receives Fast Track ... - Markets Insider
Pittsburgh, PA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of ...
Cognition Therapeutics Inc (CGTX) CEO Lisa Ricciardi on Q4 2021 ...
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2021 Earnings Call March 30, 2022 8:00 AM ETCompany ParticipantsDaniel Kontoh-Boateng - Investor RelationsLisa ...
Cognition Therapeutics Announces Closing of Public Offering
PURCHASE, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) today announced the closing of its previously announced ...
Similar Companies
Loading the latest forecasts...